Which has grown faster, MRNA or STE?

Over the past five years, STE grew revenue faster — MRNA at a -2.60% CAGR versus STE at 13.82%.

Does MRNA or STE pay a bigger dividend?

STE pays a dividend (1.20% yield) while MRNA does not currently pay one.

Is MRNA or STE more profitable?

STE runs the higher net margin — MRNA at -143.55% versus STE at 13.18%.

Which has been the better investment, MRNA or STE?

Over the past 5-year, STE delivered the higher annualized total return — MRNA at -22.95% versus STE at 13.60%. Past performance doesn't predict future results.

Moderna, Inc. (MRNA) vs STERIS plc (STE)

STE leads on 9 of 10 compared metrics.

A side-by-side comparison of Moderna, Inc. and STERIS plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 25, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — MRNA vs STE

growth of $100 · last 8y

MRNA +221.2%STE +78.3%MRNA compounded faster

MRNA STE

MRNA vs STE: by the numbers

•MRNA is the larger company ($23.71B vs $20.52B market cap).
•STE is profitable (13.18% net margin) while MRNA runs a net loss (-143.55%).
•STE grew revenue faster over the past five years (13.82% vs -2.60% CAGR).
•STE pays a dividend (1.20% yield) while MRNA does not currently pay one.

Which is better, MRNA or STE?

Metric tally: MRNA 1 · STE 9

It depends on what you're optimizing for:

GrowthSTE(faster 5Y revenue CAGR)

QualitySTE(higher ROIC)

Metrics side by side

Valuation

Metric	MRNA	STE
P/E ratio	—	26.56
Forward P/E	—	20.65
P/S ratio	10.61	3.49●
P/B ratio	3.19	2.88●
PEG ratio	—	1.03
EV / EBITDA	—	12.24
FCF yield	—	4.69%

Profitability

Metric	MRNA	STE
Gross margin	-13.89%	44.25%●
Operating margin	-153.35%	18.56%●
Net margin	-143.55%	13.18%●
ROE	-43.12%	10.89%●
ROIC	-29.70%	8.47%●

Dividends

Metric	MRNA	STE
Dividend yield	—	1.20%
Payout ratio	—	31.78%

Growth (annualized)

Metric	MRNA	STE
Revenue CAGR (5Y)	-2.60%	13.82%●
EPS CAGR (5Y)	—	11.22%
FCF CAGR (5Y)	126.92%●	16.64%
Total return CAGR (5Y)	-22.95%	1.32%●

Frequently asked

Which is better, MRNA or STE?: It depends on your goal. growth: STE (faster 5Y revenue CAGR); quality: STE (higher ROIC). Across all compared metrics, STE leads 9 to 1.
Which has grown faster, MRNA or STE?: Over the past five years, STE grew revenue faster — MRNA at a -2.60% CAGR versus STE at 13.82%.
Does MRNA or STE pay a bigger dividend?: STE pays a dividend (1.20% yield) while MRNA does not currently pay one.
Is MRNA or STE more profitable?: STE runs the higher net margin — MRNA at -143.55% versus STE at 13.18%.
Which has been the better investment, MRNA or STE?: Over the past 5-year, STE delivered the higher annualized total return — MRNA at -22.95% versus STE at 13.60%. Past performance doesn't predict future results.

Go deeper

Full MRNA analysis Full STE analysis Interactive comparison tool

Dig into the metrics

Moderna P/E ratio STERIS P/E ratio Moderna dividend yield STERIS dividend yield Moderna ROE STERIS ROE Moderna operating margin STERIS operating margin Moderna revenue growth STERIS revenue growth Moderna free cash flow STERIS free cash flow

Moderna & STERIS appear in these rankings

Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 25, 2026.